{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:30:00Z","timestamp":1791095400039,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T00:00:00Z","timestamp":1205366400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A high incidence of decreased bone mineral density (BMD) has been associated with HIV infection. Normal skeletal homeostasis is controlled, at least in part, by the maturation and activity of mature osteoblasts. Previous studies by our group have demonstrated the ability of HIV proteins to perturb osteoblast function, and the degree of osteogenesis in differentiating mesenchymal stem cells (MSCs). This study attempts to further dissect the dynamics of this effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>MSCs were cultured under both osteogenic (cultured in commercially available differentiation media) and quiescent (cultured in basal medium) conditions. Both cell populations were exposed to HIV p55-gag and HIV rev (100 ng\/ml). Time points were taken at 3, 6, 9, and 15 days for osteogenic conditions, while quiescent cells were treated for 1 week. Cell function (alkaline phosphatase [ALP] activity, calcium deposition, and lipid levels) and the activity of the key MSC transcription factors, RUNX-2 and PPARgamma were determined post-exposure. Also, in cells cultured in differentiating conditions, cellular levels of connective tissue growth factor (CTGF) were analysed using whole cell ELISA, while BMP-2 secretion was also examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In differentiating MSCs, exposure to HIV proteins caused significant changes in both the timing and magnitude of key osteogenic events and signals. Treatment with REV increased the overall rate of mineralization, and induced earlier increases in CTGF levels, RUNX-2 activity and BMP-2 secretion, than those observed in the normal course of differntiation. In contrast, p55-gag reduced the overall level of osteogenesis, and reduced BMP-2 secretion, RUNX-2 activity, CTGF levels and ALP activity at many of the timepoints examined. Finally, in cells cultured in basal conditions, treatment with HIV proteins did not in and of itself induce a significant degree of differentiation over the time period examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These data demonstrate that the effect of HIV proteins on bone is dependent on the differentiation status of the cells that they are in contact with. The effect on bone cell signalling provides insights into the mechanism of HIV induced decreases in bone mineral density.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-9-33","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T19:13:21Z","timestamp":1205435601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation"],"prefix":"10.1186","volume":"9","author":[{"given":"Eoin J","family":"Cotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Shi Ming","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Powderly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,13]]},"reference":[{"key":"439_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002030-200301030-00003","volume":"17","author":"GT Allison","year":"2003","unstructured":"Allison GT, Bostrom MP, Glesby MJ: Osteonecrosis in HIV disease: epidemiology, etiologies and clinical management. AIDS. 2003, 17: 1-9. 10.1097\/00002030-200301030-00003.","journal-title":"AIDS"},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00126334-200307010-00001","volume":"33","author":"J Thomas","year":"2003","unstructured":"Thomas J, Doherty SM: HIV infection--a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003, 33: 281-291.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"439_CR3","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1097\/00126334-200202011-00005","volume":"29","author":"WG Powderly","year":"2002","unstructured":"Powderly WG: Long term exposure to lifelong therapies. J Acquir Immune Defic Syndr. 2002, 29 (Suppl 1): S28-S40.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"439_CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/74.5.679","volume":"74","author":"A McDermot","year":"2001","unstructured":"McDermot A, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S: Effect of highly active antiretroviral therapy on fat, lean and bone mass in HIV-seropositive men and women. Am J Clin Nutr. 2001, 74: 679-86.","journal-title":"Am J Clin Nutr"},{"key":"439_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P Tebas","year":"2000","unstructured":"Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000, 14: 63-67. 10.1097\/00002030-200003100-00005.","journal-title":"AIDS"},{"key":"439_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/367569","volume":"36","author":"K Mondy","year":"2003","unstructured":"Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus infected individuals. Clin Infect Dis. 2003, 36: 482-490. 10.1086\/367569.","journal-title":"Clin Infect Dis"},{"key":"439_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004, 292: 191-201. 10.1001\/jama.292.2.191.","journal-title":"JAMA"},{"key":"439_CR8","unstructured":"Overton Et, Mondy K, Bush T, Conley L, Kojic E, Henry K, Hammer J, Wood K, Lichtenstein K, Brooks J, SUN Study Investigators: Factors associated with low bone mineral density in a large cohort of HIV-infected US adults: baseline results from the SUN study. Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections Abstract 836. Los Angeles, California, February 25\u201328, 2007"},{"key":"439_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1172\/JCI15797","volume":"114","author":"MWH Wang","year":"2004","unstructured":"Wang MWH, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG, Teitelbaum SL, Ross FP: The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signalling. J Clin Invest. 2004, 114: 206-213.","journal-title":"J Clin Invest"},{"issue":"2","key":"439_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/8756-3282(94)00028-X","volume":"29","author":"S Serrano","year":"1995","unstructured":"Serrano S, Marinoso ML, Soriano JC, Rubies-Prat J, Aubia J, Coll J, Bosch J, Del Rio L, Vila J, Goday A: Bone remodelling in Human Immunodeficiency Virus 1 Infected Patients. A histomorphometric Study. Bone. 1995, 29 (2): 185-191. 10.1016\/8756-3282(94)00028-X.","journal-title":"Bone"},{"key":"439_CR11","doi-asserted-by":"publisher","first-page":"48251","DOI":"10.1074\/jbc.M304676200","volume":"278","author":"JM Fakruddin","year":"2003","unstructured":"Fakruddin JM, Laurence J: HIV envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor \u03baB Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-\u03b3\/RANKL Cross-talk. J Biol Chem. 2003, 278: 48251-48258. 10.1074\/jbc.M304676200.","journal-title":"J Biol Chem"},{"key":"439_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/BF03345522","volume":"28","author":"F Pagani","year":"2005","unstructured":"Pagani F, Francucci CM, Moro L: Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 2005, 28: 8-13.","journal-title":"J Endocrinol Invest"},{"key":"439_CR13","first-page":"863","volume":"19","author":"Y Okada","year":"2004","unstructured":"Okada Y, Tanaka Y: Immune signals in the context of secondary osteoporosis. Histol Histopathol. 2004, 19: 863-866.","journal-title":"Histol Histopathol"},{"key":"439_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jcb.20253","volume":"94","author":"G Mbalaviele","year":"2005","unstructured":"Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R: \u03b2-Catenin and BMP-2 synergise to promote osteoblast differentiation and new bone formation. Jour Cell Biochem. 2005, 94: 403-418. 10.1002\/jcb.20253.","journal-title":"Jour Cell Biochem"},{"key":"439_CR15","doi-asserted-by":"publisher","first-page":"16502","DOI":"10.1074\/jbc.M512494200","volume":"281","author":"EJ Jeon","year":"2006","unstructured":"Jeon EJ, Lee KL, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, Oh BC, Lee KS, Lee YH, Bae SC: Bone Morphogenetic Protein-2 Stimulates RUNX2 Acetylation. J Biol Chem. 2006, 281: 16502-16511. 10.1074\/jbc.M512494200.","journal-title":"J Biol Chem"},{"key":"439_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0303-7207(03)00151-5","volume":"205","author":"L Tou","year":"2003","unstructured":"Tou L, Quibria N, Alexander JM: Transcriptional regulation of the human Runx2\/Cbfa1 gene promoter by bone morophogenic protein-7. Molec Cell Endocrin. 2003, 205: 121-129. 10.1016\/S0303-7207(03)00151-5.","journal-title":"Molec Cell Endocrin"},{"issue":"1","key":"439_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.mehy.2006.06.006","volume":"68","author":"YL Li","year":"2007","unstructured":"Li YL, Xiao ZS: Advances in Runx2 regulation and its isoforms. Med Hypotheses. 2007, 68 (1): 169-75. 10.1016\/j.mehy.2006.06.006.","journal-title":"Med Hypotheses"},{"key":"439_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI: Mesenchymal stem cells. J Ortho Res. 1991, 9: 641-650. 10.1002\/jor.1100090504.","journal-title":"J Ortho Res"},{"key":"439_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.yexcr.2005.03.018","volume":"306","author":"CA Gregory","year":"2005","unstructured":"Gregory CA, Prockop DJ, Spees JL: Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res. 2005, 306: 330-335. 10.1016\/j.yexcr.2005.03.018.","journal-title":"Exp Cell Res"},{"key":"439_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.coph.2004.03.002","volume":"4","author":"ME Nuttall","year":"2004","unstructured":"Nuttall ME, Gimble JM: Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004, 4: 290-294. 10.1016\/j.coph.2004.03.002.","journal-title":"Curr Opin Pharmacol"},{"key":"439_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00003086-197110000-00021","volume":"80","author":"P Meunier","year":"1971","unstructured":"Meunier P, Aaron J, Edouard C, Vignon G: Osteoporosis and the replacement of cell populations of the marrow by adipose tissue, A quantitative study of 84 iliac bone biopsies. Clin Orthop. 1971, 80: 147-154. 10.1097\/00003086-197110000-00021.","journal-title":"Clin Orthop"},{"key":"439_CR22","doi-asserted-by":"publisher","first-page":"55958","DOI":"10.1074\/jbc.M407810200","volume":"279","author":"Q Luo","year":"2004","unstructured":"Luo Q, Kang Q, Weike S, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC: Connective tissue growth factor (CTGF) is regulated by Wnt and Bone Morphogenetic Proteins signalling in osetoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004, 279: 55958-55968. 10.1074\/jbc.M407810200.","journal-title":"J Biol Chem"},{"key":"439_CR23","doi-asserted-by":"crossref","unstructured":"Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger KH, Trajanoski Z: Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 8: 70-10.1186\/1471-2164-8-70. 2007 Mar 12","DOI":"10.1186\/1471-2164-8-70"},{"issue":"12","key":"439_CR24","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1089\/aid.2007.0112","volume":"23","author":"EJ Cotter","year":"2007","unstructured":"Cotter EJ, Malizia AP, Chew N, Powderly WG, Doran PP: HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses. 2007, 23 (12): 1521-1530. 10.1089\/aid.2007.0112.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"439_CR25","unstructured":"NIH aids reagent program. [http:\/\/www.aidsreagent.org]"},{"key":"439_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.phymed.2007.06.007","volume":"15","author":"N Singh","year":"2008","unstructured":"Singh N, Kumar S, Singh P, Raj HG, Prasad AK, Parmar VS, Ghosh B: Piper longum Linn. Extract inhibits TNF-alpha-induced expression of cell adhesion molecules by inhibiting NF-kappaB activation and microsomal lipid peroxidation. Phytomedicine. 2008, 15: 284-291. 10.1016\/j.phymed.2007.06.007.","journal-title":"Phytomedicine"},{"key":"439_CR27","doi-asserted-by":"publisher","first-page":"18185","DOI":"10.1074\/jbc.273.29.18185","volume":"273","author":"J Dammeier","year":"1998","unstructured":"Dammeier J, Beer HD, Brauchle M, Werner S: Dexamethasone is a novel potent inducer of connective tissue growth factor expression. J Biol Chem. 1998, 273: 18185-18190. 10.1074\/jbc.273.29.18185.","journal-title":"J Biol Chem"},{"key":"439_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-5926-6-5","volume":"6","author":"L Wickert","year":"2007","unstructured":"Wickert L, Chatain N, Kruschinsky K, Gressner AM: Gluticorticoids activate TGF-\u03b2 induced PAI-1 and CTGF expression in rat hepatocytes. Comparative Hepatology. 2007, 6: 5-10.1186\/1476-5926-6-5.","journal-title":"Comparative Hepatology"},{"key":"439_CR29","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1128\/MCB.22.17.6222-6233.2002","volume":"22","author":"V Geoffry","year":"2002","unstructured":"Geoffry V, Kniessel M, Fournier B, Boyde A, Matthias P: High bone resorption in adult aging transgenic mice overexpressing cbfa1\/runx2 in cells of the osteoblastic lineage. Mol Cell Biol. 2002, 22: 6222-6233. 10.1128\/MCB.22.17.6222-6233.2002.","journal-title":"Mol Cell Biol"},{"key":"439_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","volume":"8","author":"TP Hill","year":"2005","unstructured":"Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C: Canonical wnt\/\u03b2-catenin signalling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005, 8: 727-738. 10.1016\/j.devcel.2005.02.013.","journal-title":"Dev Cell"},{"key":"439_CR31","doi-asserted-by":"publisher","first-page":"14515","DOI":"10.1074\/jbc.M700030200","volume":"282","author":"S Kang","year":"2007","unstructured":"Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD, Macdougald OA: Wnt signalling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT\/Enhancer-binding protein \u03b1 and peroxisome proliferator-activated receptor \u03b3. J Biol Chem. 2007, 282: 14515-14524. 10.1074\/jbc.M700030200.","journal-title":"J Biol Chem"},{"issue":"13","key":"439_CR32","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1089\/088922202760265597","volume":"18","author":"L Wang","year":"2002","unstructured":"Wang L, Mondal D, La Russa VF, Agrawal KC: Suppression of Clonogenic Potential of Human Bone Marrow Mesenchymal Stem Cells by HIV Type 1: Putative Role of HIV Type 1 Tat Protein and Inflamatory Cytokines. AIDS Res Hum Retroviruses. 2002, 18 (13): 917-931. 10.1089\/088922202760265597.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"439_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0268-960X(03)00021-3","volume":"17","author":"DT Scadden","year":"2003","unstructured":"Scadden DT: Stem cells and immune reconstitution in AIDS. Blood Reviews. 2003, 17: 227-231. 10.1016\/S0268-960X(03)00021-3.","journal-title":"Blood Reviews"},{"issue":"6","key":"439_CR34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jlb.57.6.948","volume":"57","author":"GN Schwartz","year":"1995","unstructured":"Schwartz GN, Kessler SW, Szabo JM, Burrell LM, Francis ML: Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cutures. J Leukoc Biol. 1995, 57 (6): 948-55.","journal-title":"J Leukoc Biol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-9-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-9-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-9-33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-9-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:11:02Z","timestamp":1630458662000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-9-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-9-33","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,13]]},"assertion":[{"value":"1 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}